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KEBERKESANAN  INTRAVENUS PARECOXIB SODIUM SEBAGAI 
ANALGESIA ALTERNATIF KEPADA  MORPHINE DALAM RAWATAN SAKIT 
BUAH PINGGANG AKUT DI JABATAN KECEMASAN HOSPITAL UNIVERSITI 
SAINS MALAYSIA 
ABSTRAK 
Pengenalan : Pesakit dengan kolik buah pinggang biasanya datang ke Jabatan 
Kecemasan dengan kesakitan yang teruk dan tidak tertanggung. Pakar Perubatan 
Kecemasan menggunakan pelbagai jenis ubat untuk merawat masalah ini, namun 
setakat ini tiada lagi  ubat yang terbukti untuk melegakan kesakitan sepenuhnya. Kajian 
ini bertujuan untuk membandingkan keberkesanan IV parecoxib berbanding IV 
morphine terhadap pesakit yang disyaki mengalami kolik buah pinggang akut di 
Jabatan Kecemasan. Objektif : Objektif kajian ini adalah untuk membandingkan antara 
IV parecoxib dan morphine di Jabatan Kecemasan HUSM mengenai pengurangan skor 
kesakitan di kalangan  pesakit kolik buah pinggang akut dari masa ke masa, 
pengurangan skor kesakitan di antara  kumpulan dari masa ke masa dan untuk 
membandingkan keberkesanan penurunan tahap kesakitan antara kedua-dua ubat 
(pengurangan sebanyak 2 skor tahap kesakitan) selepas 5 minit ubat diberi. Kesan-
kesan sampingan kedua-dua ubat juga dinilai. Methodologi : Kajian ini melalui proses 
randomisasi dan kajian buta tunggal untuk membandingkan IV parecoxib 40 mg 
dengan IV morphine 0.10mg/kg terhadap pesakit dewasa yang datang ke ED dengan 
simptom sakit buah pinggang akut dengan NRS 6 dan ke atas. Pemerhatian 
berperingkat seperti tekanan darah, denyutan nadi, tahap oksigen dan NRS dilakukan 
pada 0, 5, 15, 30 minit begitu juga dengan kesan sampingan dinilai selepas 30 minit 
ubat diberi.  Hasil utama dalam kajian ini adalah penurunan NRS. Analisis data 
 x 
 
dilakukan menggunakan ukuran berulang ANOVA. Keputusan : Keputusan kajian ini 
tidak menunjukkan perbezaan yang ketara terhadap penurunan NRS di antara pesakit 
yang menerima IV parecoxib atau morphine (F(3,126)=0.229, P=0.876). Perbandingan 
antara kesan efektif pada 5 minit di antara kumpulan adalah tidak signifikan (P=0.498). 
Pesakit yang menerima IV morphine mengalami pening, muntah dan loya masing-
masing sebanyak 22.7 %, 13.6 % dan 4.5% berbanding 4.5% mengalami loya sahaja 
dalam kumpulan parecoxib. Kesimpulan : Kajian ini menunjukkan tidak ada perbezaan 
penurunan tahap kesakitan bagi pesakit yang menerima IV morphine atau  parecoxib , 
begitu juga dengan kesan efektif pada masa selepas 5 minit ubat diberi. Berdasarkan 
kesan yang efektif dan juga kurangnya kesan sampingan, IV parecoxib mampu untuk 
dijadikan sebagai ubat penahan sakit alternatif kepada morphine dalam merawat sakit 
buah pinggang akut seterusnya diperluaskan dalam pelbagai kes di ED HUSM.  
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THE EFFECTIVENESS OF INTRAVENOUS PARECOXIB SODIUM AS AN 
ANALGESIC ALTERNATIVE TO MORPHINE IN SUSPECTED ACUTE RENAL 
COLIC IN EMERGENCY DEPARTMENT HOSPITAL UNIVERSITI SAINS 
MALAYSIA 
ABSTRACT 
Background : Patients with renal colic usually presented to Emergency Department 
with severe and excruciating pain. Emergency Physicians using numerous medications 
to treat the problem, however none of them had been proven to relieve the pain 
completely. This study aimed to compare the effectiveness of IV parecoxib versus IV 
morphine in suspected acute renal colic in Emergency Department . Objectives : The 
objectives of this study were comparison between IV parecoxib sodium and morphine 
in Emergenency Department HUSM regarding pain score reduction among acute renal 
colic patient over time,  mean pain score reduction by group over time and to compare 
the effectiveness of both analgesics (reduction by 2 pain scores) after 5 minutes of drug 
administration. The side effects of both drugs will be evaluated too. Methods : A 
randomized, single-blinded study comparing IV parecoxib 40 mg versus IV morphine 
at 0.10 mg/kg was conducted in adult patients who presented with features suggestive 
of acute renal colic and NRS of 6 or more. Periodic assessment of vital signs and NRS 
were taken at 0, 5, 15 and 30 minutes as well as evaluation of side effects within 30 
minutes after the administration of the study drugs. The primary outcome was the 
reduction of NRS. The data was analyzed by repeated measures ANOVA analysis.  
Results : There was no significant difference in the mean NRS between patients in IV 
parecoxib group and morphine group over time (F(3,126)=0.229, P=0.876). 
Comparison of the effectiveness at 5 minutes between the groups was not significant 
(P=0.498). Dizziness, vomiting and nausea were experienced in 22.7%, 13.6% and 
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4.5% of patients respectively in IV morphine group as compared to parecoxib group 
4.5% experienced of nausea only. Conclusions :  There was no significant difference in 
NRS between the groups over time, as well as in term of the effectiveness at 5 minutes. 
Due to lack of IV parecoxib side effect compared to morphine, IV parecoxib  seemed to 
be valuable in the future and can be used as analgesic alternative to morphine in acute 
renal colic as well as extended further to treat a variety of cases presented in ED 
HUSM. 
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CHAPTER 1 
INTRODUCTION 
1.1 Literature Review 
1.1.1 Background 
The commonest reason make patients seek care in Emergency Department (ED) 
is pain and emergency physicians treat many patients who have severe pain, ranging 
from shingles to long bone fractures to myocardial infarction. The volume and severity 
of pain-related problems make pain management a core skill in emergency medicine 
(Todd, et al. 2002).  
According to International Association for the Study of Pain (IASP), pain is 
described as ‗unpleasant sensory and emotional experience associated with actual or 
potential tissue damage or described in terms of such damage‘. Therefore, although the 
word pain usually refers to physical pain, it may well involve mental pain as well. 
Since pain has become a common presentation in Emergency Department (ED), 
Malaysia Ministry of Health (MOH) has been implementing pain as the 5
th
 vital sign 
together with blood pressure, heart rate, respiratory rate and temperature to all hospitals 
under MOH since 2011. All staff from all health facilities especially those in 
Emergency Department (ED) currently are being trained to make sure this 
implementation is running smoothly and accordingly since in triage area before patient 
being transferred to the treatment area. 
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1.1.2 Pain Assessment 
Valid and reliable assessment of pain is essential for both clinical trials and 
effective pain management. Assessment of acute pain from trauma or disease can be a 
simple and straightforward task (H Breivik, et al. 2008) .  
There are multiple pain assessment tools available  in assessing acute pain  such 
as visual analogue scale (VAS), numeric rating scale (NRS) and verbal categorical 
rating scale (VRS). 
The well-known visual analogue scale (VAS) and numeric rating scale (NRS) 
for assessment of pain intensity agree well and both are equally sensitive in assessing 
acute pain after surgery, and they are both superior to a four-point verbal categorical 
rating scale (VRS). They function best for the patient's subjective feeling of the 
intensity of pain right now—present pain intensity. They may be used for worst, least, 
or average pain over the last 24 h, or during the last week. However, there are some 
limitations with this, as memory of pain is not accurate and often coloured by changing 
context factors. They are also used to assess ‗unpleasantness‘ of pain and to grade 
impact of pain on function. The indicated ranges of the categories of the VRS scale on 
the numeric rating scale (NRS) are approximate, with significant variation both 
between patients and in individuals at different time points. A study using simultaneous 
recordings of pain intensity on VAS, NRS, and VRS scales in a large number of 
patients demonstrated the superiority of the VAS and NRS over VRS. A computerized 
simulation study, randomly sampling 10000 times, repeatedly from simultaneous 
observations of VAS, NRS, and VRS, documented that the power to detect a difference 
in pain intensity was higher with the NRS and the VAS data compared with the VRS 
data (H Breivik, et al. 2008). 
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However, to date there is still no specific test that can measure the severity of 
patients‘ pain. Vital signs such as blood pressure and heart rate have been showed to be 
inconsistent with the severity of pain. To infer severity, the verbal or visual analogue 
scale has become widely accepted now (Boswell M & B. Elliot Cole 2006). 
1.1.3 Renal colic 
Renal colic is a common problem presented to the ED and pain can be quite 
significant, requires a rapid and effective medical response. Emergency physicians use 
a multitude of medications for analgesia in renal colic (Safdar, et al. 2008). 
Renal colic affects 5%-12% of individuals at least once in their lifetime (Safdar, 
et al. 2006). The condition is accompanied by excruciating pain that requires prompt 
and effective pain control. The preferred route of medication administration for this 
acute pain is intravenous. Both NSAIDs and opioids are considered appropriate 
analgesics. However the most effective analgesic regimen has not been determinated 
(Safdar, et al. 2006). 
Renal colic caused by acute partial or complete ureteric obstruction due to a 
calculus in the vast majority of the cases. However, in approximately 5% of the 
patients, renal colic may be caused by conditons unrelated to a stone disease such as 
pyelonephritis and pelviureteric junction (PUJ) obstruction (Shokeir, A. A.2001).  
The traditional explanation for renal colic has been that the ureteric obstruction 
causes a direct increase in intraluminal pressure of the collecting system, physically 
stretching it, and stimulating nerve endings in the lamina propria. In response to this 
distension, the smooth muscle in the wall of the ureter contracts as it trials to move the 
stone. If the stone becomes lodges and unable to moves, these muscles develop spasm. 
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A prolonged isotonic contraction leads to increase production of lactic acid which 
irritates both slow-type A and fast-type C fibers. Afferent impulses are generated that 
travel to the spinal cord, adjoining it at the T11 to L1 levels with subsequent 
projections to higher levels of central nervous system. This pain can also be perceived 
in any organ sharing in the urinary tract innervation such as the gastrointestinal organs 
and other components of the genitourinary system (Shokeir, A. A. 2001). 
Stones in the urinary tract or bladder stones are often called; urinary stone is the 
presence of stones in the urinary tract, from the kidneys, ureters, urinary bladder into 
the urethra. Many factors that unfavorable formations of stones, yet the exact cause of 
urinary tract stones is not yet known. On the nucleation process of hydrogen, sodium, 
uric acid and uric crystals of hydroxyapatite forms the core of calcium ions and oxalate 
is then glue (adhesion) in the nucleus to form a mixture of stones. This process is called 
heterogeneous nucleation. Urinary tract stones in general contain elements of calcium 
oxalate or calcium phosphate, uric acid, magnesium ammonium phosphate (MAP), 
xanthin, and cystine. Urinary tract stones have a basic component of calcium about 
75% in the form of calcium oxalate or calcium phosphate, oxalate and phosphate 
mixture. Identification of urinary tract stones can be done with the analysis of stone, so 
that the type and composition of the stones can be known. Many found the jar of a 
stone while in the developed countries more plentiful upper urinary stones (kidney and 
ureter), this difference affected the nutritional status and mobility of daily activities. 
The average prevalence worldwide is 1-12% of the population suffer from urinary tract 
stones (Pako R.P , et al 2015). 
Renal colic can be diagnosed by clinical, biochemical and also radiological. 
Patients with renal colic usually presented with characteristic loin pain may or not 
radiated to the groin, may have vomiting and fever. They usually but not always have 
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haematuria (macroscopic or microscopic). However, 15% of patients with proven stone 
on imaging will not have haematuria. They may have a previous history of renal 
calculus (IAEM CG3 Emergency Department Management of Renal Colic & suspected 
Renal Calculus 2014). 
Biochemical Investigations also important such as urine dipstick for red cells, 
white cells and nitrites and a urine pH. Urine should be sent for culture if dipstick 
urinalysis is abnormal. Serum urea, creatinine, sodium and potassium should be 
analysed as a measure of renal function. Serum uric acid and calcium should also be 
performed if the patient has not had a previous normal result (within 1 year). This 
might be the only occasion when a patient with hypercalcaemia may be identified. 
Patients with fever should also have blood samples for CRP and FBC sent to the 
laboratory. If intervention is likely or planned a coagulation test should be considered 
(IAEM CG3 Emergency Department Management of Renal Colic & suspected Renal 
Calculus 2014). 
Stone analysis should be performed in certain high risk stone formers. This 
would include first presentation at a young age, bilateral stones or large stones at 
presentation. NCCT has become the standard method for diagnosing acute flank pain. It 
can identify the presence of the stone, its diameter and density. NCCT should be used 
to confirm a diagnosis in patients presenting with acute flank pain because it is superior 
to IVU. The radiation risk can be reduced by using low-dose CT (IAEM CG3 
Emergency Department Management of Renal Colic & suspected Renal Calculus 
2014). 
However, given that ureterolithiasis is a benign and recurrent disease, 
emergency physicians should consider diagnostic strategies that limit radiation 
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exposure.  Ultrasonography (US) is an imaging modality that may be used to 
investigate renal colic that does not expose the patient to radiation or contrast material. 
Although reported estimates of the sensitivity of ultrasonography (US) to visualize 
ureteral calculi vary widely and are lower than that of computerized tomography (CT) 
(12%–93%), ultrasound (US) is highly accurate in detecting hydronephrosis, 
perinephric fluid and abnormal urinary jets, which often indicate the presence of calculi 
with sensitivity nearing 100. The specificity of US for direct or indirect findings 
compatible with ureterolithiasis is greater than 90% in some studies. Additionally, US 
has been recognized as a useful imaging tool for patients in whom radiation exposure 
should be avoided (Edmonds M. L., et al 2010). Since US machine mostly available in 
emergency setting worldwide, so it is not possible to diagnose renal colic in ED level. 
1.1.4 Treatment of renal colic 
A variety of drugs is used for renal colic, including antispasmodics, NSAIDs 
and opioids (O‘Connor, et al.2000). 
Parecoxib is the first selective COX-2 inhibitors for parenteral administration. It 
is prodrug of Valdecoxib which is more than 28,000 fold more selective for COX-2 
versus COX-1 in vitro. It is use for acute pain management post operation. Onset of 
pain relief in 7-13 min, with a single dose of IV/IM Parecoxib Sodium 40mg. 
Analgesic lasting from 6 to more than 12 hours. Parecoxib is intravenous pro-drug that 
is metabolized to valdecoxib, is the first COX-2 agent available in North America that 
can be given by the IV and IM routes. In dental, gynaecologic and orthopaedic pain, 
parecoxib ( 20 mg IV or IM) provided a similar degree and duration of analgesia to 
intravenous ketorolac (30–60 mg), and more prolonged analgesia than IV morphine (4 
mg) (Daniels, et al. 2001) . 
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Another multicenter study in Latin America looked at the use of parecoxib in 
acute renal colic and it showed that parecoxib is  effective as ketoprofen in the 
treatment of renal colic (Glina S, et al. 2011). 
Opioids have been traditional first-line therapy for patients suffering from acute 
renal colic. The 2 most common opioids study are morphine and meperidine. A 
randomized controlled trial (RCT) comparing 10 mg of IV morphine with 100 mg of 
IV meperidine found they were equally effective. However, because of meperidine‘s 
greater abuse potential and increased side-effect profile, the authors of the study 
recommended morphine over meperidine (O'Connor, et al. 2000) 
According to meta-analysis of 20 trials (2009), NSAIDs and strong opioid 
analgesics have comparable efficacy. Morphine 5-10 mg IM in an alternative treatment 
to NSAIDs for acute pain management in patients with renal colic and preferred over 
NSAIDs in women who are pregnant. The  concomitant administration of an antiemetic 
may be considered for the prevention or control of nausea and vomiting (National 
Institute for Health and Care Excellence (NICE) Renal colic - acute 2009). A recent  
Cochrane Review on Randomized Clinical Trials comparing opioids and NSAIDs in 
acute renal colic found that both drugs reduced patient-reported pain scores (Safdar, et 
al. 2008). 
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1.2 Rationale for the study 
The cornerstone of ureteral colic management is analgesia, which can be 
achieved most expediently with parenteral narcotics or nonsteroidal anti-inflammatory 
drugs (NSAIDs). Parenteral narcotics are the mainstay of analgesia for patients with 
acute renal colic. They work primarily on the central nervous system (CNS) to reduce 
the perception of pain.  
Of the NSAIDs, the only one approved by the US Food and Drug 
Administration (FDA) for parenteral use is ketorolac. Ketorolac works at the peripheral 
site of pain production rather than on the CNS. Ketorolac has fewer adverse effects 
compared to opioids and has been proven in multiple studies to be as effective as opioid 
analgesics (J Stuart Wolf, Jr et al. 2015). 
However because parenteral Ketorolac currently not available in ED HUSM and 
and the only parenteral NSAIDs available is Parecoxib Sodium (COX -2). There were 
no studies yet regarding parecoxib sodium in managing renal colic patient. Apart from 
that, in this study we try to find an other solution despite of giving opioids in managing 
renal colic in view of adverse effects of morphine include respiratory depression, 
drowsiness, mood changes, nausea, vomiting, increases in the cerebrospinal fluid 
pressure and cough reflex depression. 
The findings from this study will provide better treatment for the future patients 
presented with acute renal colic in Emergency Department HUSM. 
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1.3 Objectives 
The general objective of this study was to determine the usage of parecoxib sodium 
(Dynastat) as an analgesic alternative to Morphine in suspected acute renal colic in ED 
HUSM. The specific objectives were: 
1. To compare mean pain score (NRS) between IV Parecoxib and IV Morphine 
groups among acute renal colic patients over time in ED HUSM , 
2. To compare mean pain score (NRS) within the groups over time, 
3. To compare effectiveness of both analgesics (reduction by 2 pain score [NRS]) 
after 5 minutes of drug administration 
4. To decribe the side effects of both drugs clinically. 
1.4 Methods 
1.4.1  Study design and participants 
This was a randomized, single-blinded study comparing IV parecoxib sodium 40 mg 
versus IV morphine at 0.10 mg/kg in adult patients presented to ED HUSM  who met 
the inclusion and exclusion criteria of  acute renal colic with NRS of 6 or more. This 
study were conducted from October 2015 until March 2016. 
1.4.2  Inclusion/exclusion/withdrawal criteria 
Inclusion criteria in this study including : 
1. Adult 18 years old and above 
2. First episode of renal colic based on clinical assessment  
3. Recurrent episode of renal colic. 
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Exclusion criteria were : 
1. Pregnant patients or breastfeeding mother 
2. Patient who had received analgesic within 6 hours of presentation 
3. Patients at high risk of cardiovascular disease 
4. Patient who are undergoing any major surgery (cardiac or major vascular 
surgery), 
5. Patients who have previously had a myocardial infarction or stroke 
6. Patients with known hypersensitivity to parecoxib sodium, valdecoxib, 
morphine or to any other ingredient of the product 
7. Patients who have experienced asthma, urticaria, or allergic-type reactions after 
taking aspirin, NSAIDs or other COX-2 specific inhibitors or after taking 
morphine 
8. Patients who have demonstrated allergic-type reactions to sulfonamides, 
patients with severe hepatic impairment (Child-Pugh score ≥10)  
9. Patient who had a history of drug dependence or were currently using 
methadone 
Patient  automatically withdrawn from this study when he or she  who initially agreed 
verbally, however after treatment given, refuse to sign the consent form and patient 
who end-up with other diagnosis after 30 days of follow up. 
1.4.3 Interventional therapy methods 
The two drugs used in this study for comparisons were IV parecoxib  sodium 
and IV morphine sulphate. The parecoxib used in this study was manufactured by 
Pharmacia & Upjohn Kalamazoo, Michigan, USA; it was produced for Pfizer using the 
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trade name of Dynastat. Each vial of Dynastat contains 40 mg of parecoxib sodium for 
reconstruction. After reconstitution, the final concentration of parecoxib is 20mg/mL.  
IV morphine sulphate was manufactured by Duopharm (M) Sdn. Bhd, Selangor, 
Malaysia. Each milliliter of injection contained 10 mg of morphine sulphate. The 
dosage for IV morphine was 0.1 mg/kg. Once was calculated based on body weight, the 
morphine solution diluted to 2 mL of volume; this to make parecoxib and morphine 
appeared identical. 
1.4.4 Procedures 
The informations regarding this study were made in each entrance in ED 
HUSM. Patients who suspected presented with  from acute renal colic with NRS score 
6 and more were triaged to yellow zone by paramedics. 
Vital signs (Blood Pressure, heart rate, respiratory rate, pulse oxymetry, 
temperature) were measured and recorded by staffnurse on duty. Treating doctor took 
prompt history as well as record patient‘s pain score according to NRS (Numeric 
Rating Scale). If the symptoms suggestive of acute renal colic and NRS score was 6 or 
more, the doctor discussed with the patient regarding this study. The patients were 
under close monitoring throughout this study for 30 minutes. Patients who agreed 
verbally may sign the consent form after medication given. The patient‘s spouse or any 
close family members are allowed to be with the patient throughout this study period 
and listened to explanation by doctor regarding this study. 
Researcher prepared envelopes which labeled as Envelope A and Envelope B. 
Each envelope was already numbered accordingly from number 1 to number 48. The 
envelope selected based on patient‘s number. For example : First patient got the  
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Envelope number 1 who is already randomized to Blok B, the second patient got the 
envelope number 2 who is randomized to Blok A and continued the same for other 
patients. 
After the patient agreed to involve in this study, the researcher took the 
envelope according to patient‘s number based on computer-generated randomization 
and the researcher prepared and administered the drug to the patient.  
Periodic assessment of vital signs ( blood pressure, pulse rate, oxygen 
saturation) and NRS taken by treating doctor  at 0, 5,15 and 30 minutes intervals after 
the administration of the study drug. 
Patient who developed side effects of the drugs within 30 minutes, prompt 
treatment  given accordingly. If no complication, the patient either discharged with 
follow up appointment at clinic or warded for further investigations.  
Patients who being discharged, information card will be provided to contact us  
to make sure patient did not get any serious side effect. 
The evaluation of the patient continued at day 30 to confirm the final diagnosis 
of the patient either really diagnose as renal colic or end up with other diagnosis. If end 
up with other diagnosis, these patient automatically withdrawn from this study.  
During this study, the patient undergone normal procedures such as blood tests 
(FBC, BUSE,CREATININE), urine test (UFEME/ C&S), radiograph if necessary 
(KUB x-ray/ KUB ultrasound).  
Bedside ultrasound KUB performed at ED to look for evidence of stone and 
hydronephrosis as well as bedside ultrasound gynaecology performed to look for 
evidence of pregnancy for women in childbearing age. 
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1.4.5 Measured parameters 
In this study, we use NRS for rating patients‘ pain score. Patients are asked to 
rate their pain on a scale from 0 to 10, where 0 represents ―no pain‖ and 10 represents 
―the worst pain possible,‖ using whole numbers (11 integers including zero). Patients 
may then be questioned as to their goals and expectations with respect to their pain 
rating as a measure of satisfaction with the degree of analgesia. Often the value of ―4‖ 
is used to confirm clinical nursing judgment as to the need for further intervention or 
documentation that the patient's goals for analgesia have been achieved. (Hartrick, et al. 
2003). In this study we use NRS ≥6 as rating for moderate to severe pain. 
1.4.6 Outcomes 
The primary outcome is reduction of NRS. If at 30 minutes, NRS was still 6 and 
more, the rescue medication given to patient ( IV morphine) and continuous close 
monitoring of the vital signs. The side effect and drug evaluation also evaluated within 
this 30 minute of drug administration. The effectiveness of drugs in this study is 
defined as the reduction of NRS by 2 score within 5 minutes of drugs administration.  
1.4.7 Sample size 
Sample size calculation was done using PS software version 3.0.43 for 
comparison of two means (α=0.05, power=80%, SD of NRS=2.3, expected difference 
in NRS=2). The calculated sample size was  22 per group of the drugs (n=44 overall). 
After considering 10% of dropout rate, the total patient needed were 24 patients per 
group (n=48 overall). 
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1.4.8 Randomization 
Patients were randomized into two groups using a computer-generated 
randomization  https://www.sealedenvelope.com/randomisation/simulation/ (random 
block size) (Kernan, et al 1999). 
Blok A (Parecoxib)  : Patient‘s Number : 2, 3, 6, 7, 9, 11, 12, 13, 14, 16, 22,   
                                                                23, 24, 25, 26, 27, 28, 31, 32, 36, 37, 38, 42, 44 
Blok B (Morphine) : Patient‘s Number : 1, 4, 5, 8, 10, 15, 17, 18, 19, 20, 21, 29, 30 
                            33, 34, 35, 39, 40, 41, 43, 45, 46, 47, 48 
1.4.9 Technique of blinding 
This study was single blinded which means  blind to the patient  and blind to the 
treating doctor. This able to avoid bias during the assessment because the same doctor  
did the assessment to the patient. The drugs were prepared and administered by the 
researcher who was not blinded in this study 
1.4.10 Ethical Approval 
This study was conducted with the approval by Human Research Ethics 
Committee Universiti Sains Malaysia (HREC) on 13th October 2015 ( 
Ref.USM/JEPeM/14120523).  
1.4.11 Statistical methods 
Data entry and statistical analyses were done using Statistical Package for 
Social Science (SPSS) version 22.0 software. The data was  analyzed by repeated 
measures ANOVA. 
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2.1 Document submitted 
THE EFFECTIVENESS OF IV PAREXOCIB SODIUM AS AN ANALGESIC 
ALTERNATIVE TO MORPHINE IN SUSPECTED ACUTE  RENAL COLIC IN 
EMERGENCY DEPARTMENT HUSM 
DEFINITION 
Renal colic is clinical diagnosis. It is diagnose mainly from history and clinical 
examination. The classic presentation for a patient with acute renal colic is the sudden 
onset of severe pain originating in the flank and radiating inferiorly and anteriorly; at 
least 50% of patients will also have nausea and vomiting.   
The diagnosis of nephrolithiasis is often made on the basis of clinical symptoms 
alone, although confirmatory tests are usually performed. 
Examination in patients with nephrolithiasis includes the following findings: 
 Dramatic costovertebral angle tenderness; pain can move to upper/lower 
abdominal quadrant with migration of ureteral stone 
 Generally unremarkable abdominal evaluation: Possibly hypoactive bowel 
sounds; usually absence of peritoneal signs; possibly painful testicles but 
normal-appearing 
 Constant body positional movements (eg, writhing, pacing) 
 Tachycardia 
 Hypertension 
 Microscopic hematuria                        ( J Stuart Wolf Jr, MD, FACS et.al 2014) 
19 
 
1. Patients suspected dependent to opioid will be identified with several indicators 
including: 
a) Requesting a specific drug and refusing all other suggestions ( may 
display considerable knowledge of drugs) 
b) Presenting with inconsistents symptoms being reported ( does not appear 
suffer significant pain) 
2. Single blind in this study means : 
a) Blind to the patient  
b) Blind to the treating doctor who will further  do  assessment to the patient 
for  30 minutes after drug  administration 
 This is to prevent bias during assessment because the same doctor  
will do the assessment to the patient. 
c) The drugs will be prepared and administered by the PI who is not blinded 
in this study 
OBJECTIVES 
a. General  
 Parecoxib Sodium (Dynastat) as an analgesic alternative to Morphine in 
suspected Acute Renal Colic in Emergency Department (ED) HUSM. 
b. Specific 
1. To compare mean pain score reduction between IV Parecoxib and IV 
Morphine among acute renal colic patient over time in ED HUSM  
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2. To compare mean pain score reduction by group over time 
3. To compare effectiveness of both analgesics ( reduction by 2 pain score) 
after 5 minutes of drug administration. 
4. To decribe the side effects of both drugs on clinical and PERFORMA  
  
BACKGROUND 
Pain is the most common reason patients seek care in emergency departments 
(ED), and emergency physicians treat many patients who have severe pain, ranging 
from shingles to long bone fractures to myocardial infarction. The volume and severity 
of pain-related problems make pain management a core skill in emergency medicine 
(Todd, Sloan et al. 2002). 
Renal colic is a very common problem presented to the emergency department 
(ED). Pain can be quite significant and requires a rapid and effective medical response 
.Emergency physicians use a multitude of medications for analgesia in renal colic 
(Safdar, Degutis et al. 2008). 
A variety of drugs is used for this condition, including antispasmodics, NSAIDs 
and opioids (O'Connor, Schug et al. 2000) . 
Parecoxib is the 1st selective COX-2 inhibitors for parenteral administration. Is 
a prodrug of Valdecoxib which is more than 28,000 fold more selective for COX-2 
versus COX-1 in vitro. It is use for acute pain management post operation. Onset of 
pain relief in  7- 13 min, with a single dose of IV/IM Parecoxib Sodium 40mg. 
Analgesic lasting from 6 to more than 12hrs. Parecoxib is intravenous prodrug that is 
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metabolized to valdecoxib, is the first COX-2 agent available in North America that can 
be given by the IV and IM routes. In dental, gynecologic, and orthopedic pain, 
parecoxib (20 mg IV or IM) provided a similar degree and duration of analgesia to 
intravenous ketorolac (30–60 mg), and more prolonged analgesia than IV morphine (4 
mg) (Daniels, Grossman et al. 2001) . 
Opioids have been traditional first-line therapy for patients suffering from acute 
renal colic. The 2 most common opioids study are morphine and meperidine. A 
randomized controlled trial (RCT) comparing 10 mg of IV morphine with 100 mg of 
IV meperidine found they were equally effective. However, because of meperidine’s 
greater abuse potential and increased side-effect  profile, the authors of the study 
recommended morphine over meperidine (O'Connor, Schug et al. 2000) . 
Renal colic affects 5%-12% of individuals at least once in their lifetime. The 
condition is accompanied by excruciating pain that requires prompt and effective pain 
control. The preferred route of medication administration for this acute pain is 
intravenous. Both NSAIDs and opioids are considered appropriate analgesics. However 
the most effective analgesic regimen has not been determinated (Safdar, Degutis et al. 
2006) 
According to meta-analysis of 20 trials (2009), NSAIDs and strong opioid 
analgesics have comparable efficacy.  
Morphine 5-10 mg IM in an alternative treatment to NSAIDs for acute pain 
management in patients with renal colic and preferred over NSAIDs in women who are 
pregnant. The  concomitant administration of an antiemetic may be considered for the 
prevention or control of nausea and vomiting (National Institute for Health and Care 
Excellence (NICE). Renal colic - acute. 2009).  
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 A recent  Cochrane Review on Randomized Clinical Trials comparing opioids 
and NSAIDs in acute renal colic found that both drugs reduced patient-reported pain 
scores (Safdar, Degutis et al. 2008). 
METHODOLOGY 
i. Research Design  
 A randomized, single-blinded study comparing IV parecoxib sodium 40 
mg versus IV morphine at 0.10 mg/kg in adult patients presented to 
Emergency Department HUSM  with acute renal colic with NRS of 6 or 
more. 
 Patients will be randomized using a computer-generated randomization ( 
two bock randamization). Each block consist of 24 patients.  
 Researcher will prepare envelopes which labelled as Envelope A  and 
Envelope B . Each envelope will be numberized accordingly from 
number 1 to number 48. The envelope will be selected based on 
patient’s number. For example : First patient will get Envelope number 
1 that will be randomized to Blok B, the second patient will get 
envelope number 2 that will be randomized to Blok A and continued the 
same for other patients. 
 After the patient agree participate in this study, the researcher will take 
the envelope according to patient’s number based on computer-
generated randomization and the researcher will prepare and administer 
the drug to the patient. 
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 Periodic assessment of vital signs ( blood pressure, pulse rate, oxygen 
saturation) and NRS will be taken by treating doctor  at 0, 5,15 and 30 
minutes intervals after the administration of the study drug. 
 The primary outcome is reduction of NRS. If at 30 minutes, NRS is still 
6 and more, the rescue medication will be given to patient ( IV 
morphine) and close monitoring of the vital signs will be continued. 
 Side effect and drug evaluation also will be evaluated within this 30 
minute of drug administration. 
ii.  Inclusion Criteria 
1 Adult 18 years old and above  
2 First episode of renal colic based on clinical assessment 
3 Recurrent episode of renal colic 
iii. Exclusion Criteria 
1. Pregnant patients or breastfeeding mother 
2. Had received analgesic within 6 hours of presentation 
3. Patients patients at high risk of cardiovascular disease (including 
patients with diabetes, ischaemic heart disease, cardiac failure, 
hyperlipidaemia, hypertension, or smokers) who are undergoing any 
major surgery (cardiac or major vascular surgery). 
4. Patients who have previously had a myocardial infarction or stroke. 
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5. Patients with known hypersensitivity to parecoxib sodium, valdecoxib, 
morphine or to any other ingredient of the product.  
6. Patients who have experienced asthma, urticaria, or allergic-type 
reactions after taking aspirin, NSAIDs or other COX-2 specific 
inhibitors, or after taking morphine as well 
7. Patients who have demonstrated allergic-type reactions to sulfonamides 
8. Patients with severe hepatic impairment (Child-Pugh score ≥10) 
9. Had a history of drug dependence or were currently using methadone 
iv. Withdrawal Criteria 
1. Patient who initially agreed verbally, however after treatment given, 
refuse to sign the consent form 
2. Patient who end-up with other diagnosis after 30 days of follow up 
v. Sampling Design and Sample Size 
                  Low population sample size – 22 for each group of study drugs 
 Total 44 patient (n = 44) 
 N + 10% = 44/1-0.1  
        = 44/0.9 
   = 48 
          So after considering 10% dropout, each study drug consist of 24 patients 
        Blok A ( Parecoxib sodium) 
